Startups

Dxcover: Multiomic Spectral Analysis Company Raises Funding

By Amit Chowdhry ● Feb 3, 2025

Dxcover Limited, a clinical-stage diagnostics company pioneering its multiomic spectral analysis (MOSA-Dx) for early detection of solid tumor cancers, announced its next key stage of growth with the closing of significant funding to drive innovation and expand its commercial presence. The funding, which will total $6.2 million, underpins the confidence of the investors in Dxcover’s mission to transform cancer diagnostics and save lives by delivering the earliest cancer diagnosis possible. This also brings the total funding raised by Dxcover to $21.4 million since spinning out from the University of Strathclyde in 2019.

SimpliGov: Strategic Growth Investment Raised From JMI Equity

By Amit Chowdhry ● Feb 3, 2025

SimpliGov - a leading no-code workflow automation platform for government organizations - announced a strategic growth investment from JMI Equity, a growth equity firm focused on investing in leading software companies.

Atalanta Therapeutics: $97 Million (Series B) Raised For Advancing Two RNAi Therapies

By Amit Chowdhry ● Feb 3, 2025

Atalanta Therapeutics, a biotechnology company advancing RNA interference (RNAi) for the treatment of neurological diseases, announced the completion of a $97 million Series B funding to support Phase 1 clinical trials of the company’s investigational RNAi therapies for KCNT1-related epilepsy and Huntington’s disease. The funding was co-led by EQT Life Sciences and Sanofi Ventures, with participation from other new investors RiverVest Venture Partners, funds managed by abrdn Inc, Novartis Venture Fund, Pictet Alternative Advisors, Mirae Asset Financial Group, and GHR Foundation alongside existing investor F-Prime Capital.

Lutris Pharma: $30 Million Funding Raised For Advancing Development Of Anti-Cancer Drug Effectiveness

By Amit Chowdhry ● Feb 3, 2025

Lutris Pharma - a clinical-stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity - announced that it has secured $30 million in financing to advance the development of LUT014, an innovative topically applied gel aimed at reducing EGFRi-induced rashes, a common adverse side effect of these cancer-fighting therapies. This funding round was led by Columbus Venture Partners and Pontifax Venture Capital, an existing investor, with Peregrine Ventures and aMoon Fund also participating.

Onebrief: $103 Million Total Raised For Transforming Military Staffs

By Amit Chowdhry ● Feb 3, 2025

Onebrief, a leading software for operational planning and military staff workflows, announced the completion of its Series C funding round. The company raised $50 million, bringing its total capital to $103 million. General Catalyst and Insight Partners led the Series C funding round, with participation from Caffeinated Capital, 9Yards Capital, and Human Capital.

Blink Ops: $50 Million In Total Funding And 400% Year-Over-Year Revenue Growth

By Amit Chowdhry ● Feb 3, 2025

Blink Ops, an AI security automation platform, announced record growth marked by a 400% increase in year-over-year revenue and over $50 million in total funding. And as organizations look to automate security operations and utilize the power of AI, Blink Ops’ unique approach—combining AI agent capabilities with a reliable, deterministic workflow engine—is rapidly propelling its adoption across security operations.

Amplitude Vascular Systems: Medical Device Company Secures $36 Million (Series B)

By Amit Chowdhry ● Feb 3, 2025

Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL platform, announced that it has completed a Series B round of financing of $36M. This funding will support the U.S. peripheral commercial launch and U.S. coronary and carotid IDE trials for the company’s Pulse Intravascular Lithotripsy (PIVL) device.

Clarametyx Biosciences: Investment Raised From Kineticos AMR Accelerator Fund

By Amit Chowdhry ● Feb 3, 2025

Clarametyx Biosciences (a clinical-stage company developing targeted and immune-enabling biologic therapies to counter persistent infections associated with biofilms) and Kineticos Life Sciences (a life sciences investor focused on companies looking to disrupt how drugs are developed, diseases are diagnosed, and patients are treated) announced an investment by the Kineticos AMR Accelerator Fund I. Aligned with the funding, KAMRA Venture Partner Douglas Thomson will join the Clarametyx Board of Directors.

Lindus Health: ‘Anti-CRO’ Company Raises $55 Million (Series B)

By Amit Chowdhry ● Feb 3, 2025

Lindus Health, an the anti-CRO running faster and more reliable clinical trials, announced it has raised $55 million in Series B funding. This funding round was led by new investor Balderton Capital, with support from Visionaries Club and existing investors Creandum, Firstminute, and Seedcamp.

Hone Health: $33 Million (Series A) Raised And ivee Acquisition

By Amit Chowdhry ● Feb 2, 2025

Hone Health, a leading telehealth clinic specializing in preventative and proactive longevity care, announced that it crossed 300,000 patients tested, 55,000 patients treated, and completed a $33 million Series A funding round with participation by Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs, and Agent Capital. This brings Hone Health's total funding to $39 million.

Helion: Fusion Energy Company Raises $425 Million (Series F) At $5.425 Billion Valuation

By Amit Chowdhry ● Feb 2, 2025

Fusion energy company Helion announced a $425 million Series F funding round that will be used to scale commercialization efforts for the company’s fusion technology. This oversubscribed and upsized round had participation from new investors, including Lightspeed Venture Partners, SoftBank Vision Fund 2, and a major university endowment, and existing investors, including Sam Altman, Mithril Capital, Capricorn Investment Group, Dustin Moskovitz through Good Ventures Foundation, and Nucor. This latest funding round will bring the total invested in Helion to over $1 billion and value the company at $5.425 billion post-money.

Quibim: Imaging Biomarker Company Raises $50 Million (Series A)

By Amit Chowdhry ● Feb 2, 2025

Quibim, a leading health technology company pioneering imaging biomarkers for precision medicine, announced the closing of its $50 million Series A funding round. And the company has experienced remarkable growth in the number of patients analyzed by its products over the past year. This funding was led by Asabys (through its fund Sabadell Asabys II) and Buenavista Equity Partners (through the BHG I fund, created in partnership with Columbus Venture Partners), and joined by UI Investissements, and GoHub Ventures as new investors. Current investors also joined them: Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures and Leadwind (KFund’s early growth fund), and individual investors, including Tony Fadell (Build Collective Principal, Nest founder and inventor of the iPod), and Dr. Jonathan Milner (founder of Abcam).

Darwin CX: Customer Experience Company Raises $12 Million

By Amit Chowdhry ● Feb 2, 2025

Darwin CX, a SaaS provider focused on transforming customer experience (CX) for publishers and subscription-based businesses, announced a significant expansion in funding and leadership.

BOW: Universal Robotics Software Company Raises £4 Million (Seed)

By Amit Chowdhry ● Feb 2, 2025

BOW, a universal robotics software company, has announced closing a £4 million seed round. The funding round was led by Northern Gritstone with co-investors Finance Yorkshire and Praetura Ventures as part of the Northern Powerhouse Investment Fund II. This news follows the appointment in November 2024 of Liz Upton, Co-Founder of Raspberry Pi, as Chair of BOW’s board.

Eclypsium: $45 Million (Series C) Closed To Enhance Supply Chain Security

By Amit Chowdhry ● Feb 2, 2025

Eclypsium, an innovator in infrastructure supply chain security, announced it raised $45 million through a combination of equity and debt in an oversubscribed Series C funding round with Qualcomm Ventures, Pavilion Capital, Singtel Innov8, and Sixty Degree Capital. These new investors are joined by previous lead investors Ten Eleven Ventures, Andreessen Horowitz, and Madrona. This funding round brings the company’s equity to $85 million.

VideaHealth: $40 Million (Series B) Secured To Transform Dental Care

By Amit Chowdhry ● Feb 2, 2025

VideaHealth, a leading dental AI company, has secured $40 million in an oversubscribed Series B funding round. Headed by Emily Melton, co-founder and managing partner of Threshold Ventures, with participation from Avenir, BAM Corner Point, and existing investors Spark Capital, Zetta Venture Partners, and Pillar VC, this new funding will enable VideaHealth to scale its AI platform, expand partnerships, and introduce innovative tools to meet the growing demand for AI-based solutions from DSOs and individual dentists.

Hypori: $12 Million (Series B Extension) Raised For Driving Zero Trust BYOD Programs

By Amit Chowdhry ● Feb 2, 2025

Hypori, a mobile access platform provider enabling secure virtual access to enterprise apps and data from any mobile device with total personal privacy, announced the completion of a strategic $12 million Series B extension. The funding round, including investments from UBS AG (UBS), Carahsoft Technology Group (Carahsoft), and AE Industrial Partners (AE Industrial), positions Hypori to accelerate the adoption of zero-trust bring-your-own-device (BYOD) programs through a secure mobile access platform technology in existing and emerging markets. With the closing of this extension, Hypori raised $35 million in Series B funding.